Success Metrics

Clinical Success Rate
85.9%

Based on 73 completed trials

Completion Rate
86%(73/85)
Active Trials
30(19%)
Results Posted
11%(8 trials)
Terminated
12(8%)

Phase Distribution

Ph phase_4
4
3%
Ph early_phase_1
1
1%
Ph phase_1
3
2%
Ph phase_2
4
3%
Ph not_applicable
73
46%
Ph phase_3
9
6%

Phase Distribution

4

Early Stage

4

Mid Stage

13

Late Stage

Phase Distribution94 total trials
Early Phase 1First-in-human
1(1.1%)
Phase 1Safety & dosage
3(3.2%)
Phase 2Efficacy & side effects
4(4.3%)
Phase 3Large-scale testing
9(9.6%)
Phase 4Post-market surveillance
4(4.3%)
N/ANon-phased studies
73(77.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.9%

73 of 87 finished

Non-Completion Rate

16.1%

14 ended early

Currently Active

30

trials recruiting

Total Trials

158

all time

Status Distribution
Active(36)
Completed(73)
Terminated(14)
Other(35)

Detailed Status

Completed73
unknown35
Recruiting21
Terminated12
Active, not recruiting9
Not yet recruiting5

Development Timeline

Analytics

Development Status

Total Trials
158
Active
30
Success Rate
85.9%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (1.1%)
Phase 13 (3.2%)
Phase 24 (4.3%)
Phase 39 (9.6%)
Phase 44 (4.3%)
N/A73 (77.7%)

Trials by Status

withdrawn21%
recruiting2113%
enrolling_by_invitation11%
active_not_recruiting96%
unknown3522%
not_yet_recruiting53%
terminated128%
completed7346%

Recent Activity

Clinical Trials (158)

Showing 20 of 158 trialsScroll for more
NCT03233711Phase 3

Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer

Active Not Recruiting
NCT07090291Not Applicable

China Colorectal Cancer Screening Trial 1 (C-Cost1)

Recruiting
NCT05630794Phase 1

Testing for Safety and Colorectal Cancer Preventive Effects of ONC201

Recruiting
NCT05419011Phase 2

Testing a Combination of Vaccines for Cancer Prevention in Lynch Syndrome

Active Not Recruiting
NCT04929028Phase 2

Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer

Active Not Recruiting
NCT07503847Not Applicable

Shared Decision-Making for Colorectal Cancer Screening in High-Risk First-Degree Relatives Aged 40-49

Enrolling By Invitation
NCT07502469

Study Comparing the Contribution of G-Eye Combined With CAD-Eye Versus High-definition Colonoscopy With CAD-Eye in the Detection of Colonic Lesions After a Positive Immunological Test in the Context of Organized Colorectal Cancer (BENEFIT)

Completed
NCT06776913Not Applicable

Randomized Controlled Trial Comparing Adult to Pediatric Colonoscope in Obese Patients.

Completed
NCT05067595Phase 1

Fecal Microbiota Transplant and Dietary Fiber Supplementation for the Treatment of Gut Graft Versus Host Disease

Recruiting
NCT05869838

A Clinical Study on Endoscopic and Histopathological Outcomes of Screening and Surveillance Colonoscopies

Completed
NCT00748449Not Applicable

Colonography Versus Colonoscopy in High Risk Patient

Terminated
NCT05976763Phase 3

Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma

Recruiting
NCT07361575Not Applicable

Study Comparing the Quality of Colon Cleanliness With Prepackaged LRD (Low-residue Diet) vs. Guided (POG).

Not Yet Recruiting
NCT07359313Not Applicable

Incidence of Colon Ischemia in Patients After Cardiopulmonary Resuscitation (CPR)

Not Yet Recruiting
NCT07355777Not Applicable

Video Tutorial and Oral Explanation Vs Oral Explanation Alone in Colonoscopy Preparation

Recruiting
NCT06453720

Predicting IBD Treatment Outcomes With Gut Microbiome Analysis

Recruiting
NCT05643859Not Applicable

Impact of Dietary Fiber Supplementation on Colonic Microbiome

Recruiting
NCT06983639Not Applicable

Randomized Trial Comparing Fecal Testing (FIT) to Colonoscopy for Post-polypectomy Surveillance

Recruiting
NCT07245173Not Applicable

Randomized Control Trial Comparing the Incidence of Loop Formation in Colonoscopy Techniques

Not Yet Recruiting
NCT04336397Not Applicable

Stool DNA to Improve Colorectal Cancer Screening Among Alaska Native People

Completed

Drug Details

Intervention Type
PROCEDURE
Total Trials
158